Skip to main content

1 Result(s)

within Emma Gränsmark Remove this filter

and

  1. Article

    Open Access

    Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel

    In recent years treatment options for advanced pancreatic cancer have markedly improved, and a combination regimen of gemcitabine and nab-paclitaxel is now considered standard of care in Sweden and elsewhere. ...

    Hakon Blomstrand, Henrik Green, Mats Fredrikson, Emma Gränsmark… in BMC Cancer (2020)

    Download PDF (1526 KB) View Article